McGlinn Cancer Institute at Reading Hospital — West Reading, Pennsylvania

McGlinn Cancer Institute at Reading Hospital is a clinical research site located in West Reading, Pennsylvania, United States 19611.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

McGlinn Cancer Institute at Reading Hospital has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Non-Hodgkin Lymphoma, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer.

Sponsors: Genentech, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in West Reading

Browse all research sites in Pennsylvania · View every site in West Reading

• Reading Hospital - Children's Health Center
• McGlinn Cancer Institute Reading Hospital
• Reading Hospital; McGlinn Cancer Institute /ID# 259181
• Reading Hospital McGlinn Cancer Institute
• Reading Hospital Clinical Trials Office /ID# 213763
• Tower Health Reading Hospital
• Reading Hospital Clinical Trials Office
• 8401179 - Reading Hospital
• Reading Hospital - Women's Health Center
• Reading Hospital Tower Health
• Reading Hospital Labor & Delivery

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for McGlinn Cancer Institute at Reading Hospital?

McGlinn Cancer Institute at Reading Hospital has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has McGlinn Cancer Institute at Reading Hospital conducted?

McGlinn Cancer Institute at Reading Hospital has 2 clinical trials on record, with 2 currently active. Their work covers Non-Hodgkin Lymphoma, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer.

Is McGlinn Cancer Institute at Reading Hospital accredited by Crixeo Clinical Trials?

McGlinn Cancer Institute at Reading Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about McGlinn Cancer Institute at Reading Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.